Article
Chromosome and molecular abnormalities in myelodysplastic syndromes.
International journal of hematology - 1 Jun 2001
Fenaux Pierre
Abstract excerpt
Cytogenetic abnormalities are seen in approximately 50% of cases of myelodysplastic syndrome (MDS) and 80% of cases of secondary MDS (following chemotherapy or radiotherapy). These abnormalities generally consist of partial or complete chromosome deletion or addition (del5q, -7, +8, -Y, del20q), whereas balanced or unbalanced translocations are rarely found in MDS. Fluorescence hybridization techniques...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
